BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+7.64%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.56B
AUM Growth
+$6.56B
(+0.3%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
37.22%
Holding
183
New
22
Increased
65
Reduced
79
Closed
14
Top Buys
| 1 |
DexCom
DXCM
|
$42.5M |
| 2 |
Cooper Companies
COO
|
$31.6M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$17.8M |
| 4 |
SI-BONE Inc
SIBN
|
$16.6M |
| 5 |
Steris
STE
|
$16.5M |
Top Sells
| 1 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$114M |
| 2 |
Intuitive Surgical
ISRG
|
$59.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$51.7M |
| 4 |
Evolent Health
EVH
|
$29.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Healthcare | 99.12% |
| 2 | Industrials | 0.77% |
| 3 | Technology | 0.02% |
| 4 | Communication Services | 0.02% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ESSA Pharma
EPIX
$11.4M
| $67M | 1.02% | 7,889,583 -9,000 | -0.1% | -$76.4K |
|
27
Immunocore
IMCR
$1.62B
| $63.2M | 0.96% | 972,254 -3,800 | -0.4% | -$247K |
|
28
Biohaven
BHVN
$1.63B
| $62.9M | 0.96% | 1,150,000 +75,000 | +7% | +$4.1M |
|
29
Option Care Health
OPCH
$4.65B
| $62.6M | 0.96% | 1,867,263 -71,544 | -4% | -$2.4M |
|
30
Charles River Laboratories
CRL
$8.04B
| $62.2M | 0.95% | 229,697 +11,941 | +5% | +$3.24M |
|
31
Insmed
INSM
$28.8B
| $58.1M | 0.89% | 2,141,843 -149,115 | -7% | -$4.05M |
|
32
Axsome Therapeutics
AXSM
$6.05B
| $54.7M | 0.83% | 685,476 +50,104 | +8% | +$4M |
|
33
Bio-Rad Laboratories Class A
BIO
$8.06B
| $54.2M | 0.83% | 156,618 +15,471 | +11% | +$5.35M |
|
34
HCA Healthcare
HCA
$94.5B
| $53.3M | 0.81% | 159,703 +7,525 | +5% | +$2.51M |
|
35
Elevance Health
ELV
$71.8B
| $51.1M | 0.78% | 98,612 -9,176 | -9% | -$4.76M |
|
36
Align Technology
ALGN
$10.3B
| $50.8M | 0.77% | 154,909 -4,498 | -3% | -$1.47M |
|
37
Idexx Laboratories
IDXX
$51.8B
| $50.4M | 0.77% | 93,358 -752 | -0.8% | -$406K |
|
38
Insulet
PODD
$23.9B
| $50.4M | 0.77% | 293,828 +3,928 | +1% | +$673K |
|
|
ACCD
39
DELISTED
Accolade, Inc. Common Stock
ACCD
| $50.4M | 0.77% | 4,804,514 +297,110 | +7% | +$3.11M |
|
40
Relay Therapeutics
RLAY
$619M
| $49.2M | 0.75% | 5,926,618 -9,464 | -0.2% | -$78.6K |
|
|
41
Evolent Health
EVH
$1.12B
| $48.6M | 0.74% | 1,483,096 -893,896 | -38% | -$29.3M |
|
42
Humana
HUM
$36.5B
| $47M | 0.72% | 135,541 +35,069 | +35% | +$12.2M |
|
43
Inspire Medical Systems
INSP
$2.77B
| $46.8M | 0.71% | 217,694 +2,094 | +1% | +$450K |
|
44
GE HealthCare
GEHC
$33.7B
| $46.6M | 0.71% | 512,230 -22,954 | -4% | -$2.09M |
|
45
Exelixis
EXEL
$10.1B
| $45.2M | 0.69% | 1,903,200 -204,900 | -10% | -$4.86M |
|
46
Eli Lilly
LLY
$657B
| $45.1M | 0.69% | 57,965 +1,753 | +3% | +$1.36M |
|
47
Procept Biorobotics
PRCT
$2.23B
| $44M | 0.67% | 890,114 +4,768 | +0.5% | +$236K |
|
48
Black Diamond Therapeutics
BDTX
$157M
| $43.2M | 0.66% | 8,517,839 -18,000 | -0.2% | -$91.3K |
|
49
CRISPR Therapeutics
CRSP
$4.71B
| $42.3M | 0.64% | 619,950 -280,450 | -31% | -$19.1M |
|
50
CareDx
CDNA
$727M
| $41.7M | 0.64% | 3,934,006 -20,786 | -0.5% | -$220K |
|